Published in Trends Mol Med on October 16, 2012
Clostridium difficile infection in the twenty-first century. Emerg Microbes Infect (2013) 1.09
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol (2016) 1.03
In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B. Infect Immun (2013) 0.98
Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr (2013) 0.98
The host immune response to Clostridium difficile infection. Ther Adv Infect Dis (2013) 0.96
Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab. Infect Immun (2014) 0.94
Role of microbiota and innate immunity in recurrent Clostridium difficile infection. J Immunol Res (2014) 0.93
Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol (2016) 0.90
Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen. Gut Microbes (2014) 0.86
New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains. Infect Immun (2014) 0.83
The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Mol Immunol (2014) 0.81
Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. Anaerobe (2016) 0.79
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection. Antimicrob Agents Chemother (2015) 0.78
The microbiota and immune response during Clostridium difficile infection. Anaerobe (2016) 0.75
Clostridium difficile-induced colitis in mice is independent of leukotrienes. Anaerobe (2014) 0.75
Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection. Anaerobe (2015) 0.75
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration. Clin Exp Immunol (2017) 0.75
An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54
Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med (2011) 10.29
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis (2006) 7.64
Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med (2010) 7.37
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med (2000) 6.24
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology (1978) 5.91
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ (2005) 5.59
Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
The role of toxin A and toxin B in Clostridium difficile infection. Nature (2010) 5.32
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol (2005) 5.26
Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis (2005) 4.89
Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med (2011) 4.62
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet (2001) 4.59
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis (2011) 4.09
The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol (2011) 3.92
Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis (2008) 3.50
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun (2011) 2.87
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol (2007) 2.83
Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med (2010) 2.71
Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol (2011) 2.71
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes (2011) 2.37
Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog (2009) 2.29
Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology (1994) 2.28
Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest (1994) 2.25
Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis (1990) 2.17
Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect Immun (2006) 2.09
Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis (1983) 2.03
Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet (1992) 2.00
Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis (2006) 1.99
Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol (2002) 1.94
Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun (2001) 1.88
Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One (2010) 1.87
Toxin A-negative, toxin B-positive Clostridium difficile. Int J Infect Dis (2006) 1.85
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). Vaccine (2009) 1.85
Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology (2010) 1.83
Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol (2010) 1.82
p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest (2000) 1.68
Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol (2009) 1.66
Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol (2001) 1.65
Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol (2011) 1.63
Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol (2000) 1.63
Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun (2002) 1.55
Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol (2011) 1.54
Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun (2011) 1.53
New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents (2009) 1.52
Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol (2012) 1.46
Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun (1991) 1.42
A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog (2011) 1.39
Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med (1998) 1.39
Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol (1991) 1.34
Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis (2011) 1.29
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog (2011) 1.28
Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis. J Immunol (2004) 1.28
The host immune response to Clostridium difficile. J Med Microbiol (2011) 1.27
Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun (1999) 1.25
Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. J Immunol (1998) 1.25
Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology (1998) 1.24
Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes. J Immunol (1999) 1.21
Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J Clin Microbiol (2010) 1.21
Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J Clin Invest (1999) 1.20
Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci U S A (2004) 1.19
Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology (2002) 1.17
The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol (2011) 1.14
A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. Clin Infect Dis (2010) 1.11
Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis. Infect Immun (1998) 1.10
Early functional effects of Clostridium difficile toxin A on human colonocytes. Gastroenterology (1997) 1.05
Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A. Microbiol Immunol (2002) 1.04
Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages. Microb Pathog (2009) 0.99
Clostridium difficile toxins A and B directly stimulate human mast cells. Infect Immun (2007) 0.97
Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats. Am J Physiol (1999) 0.97
Clostridium difficile toxin. Pharmacol Ther (1981) 0.96
Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology (2003) 0.95
Immunological properties of surface proteins of Clostridium difficile. J Med Microbiol (2005) 0.95
Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine. J Clin Invest (1994) 0.94
Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice. Gastroenterology (2002) 0.93
Heterogeneity of Clostridium difficile isolates from infants. Eur J Pediatr (1993) 0.93
Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression. J Immunol (2010) 0.92
Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice. Gut (2008) 0.90
Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes. Infect Immun (1987) 0.88
Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains. J Med Microbiol (2011) 0.88
TcdB or not TcdB: a tale of two Clostridium difficile toxins. Future Microbiol (2011) 0.88
Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls. J Med Microbiol (2008) 0.86
Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen. FEMS Immunol Med Microbiol (2011) 0.86
Amebiasis. N Engl J Med (2003) 5.63
The genome of the protist parasite Entamoeba histolytica. Nature (2005) 5.33
Laboratory diagnosis of amebiasis. Clin Microbiol Rev (2003) 2.57
Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis (2013) 2.43
Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis (2011) 2.38
Prospective case-control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh. Clin Infect Dis (2009) 2.35
Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. Am J Trop Med Hyg (2007) 2.29
Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med (2012) 2.29
Entamoeba moshkovskii infections in children, Bangladesh. Emerg Infect Dis (2003) 2.11
High throughput multiplex PCR and probe-based detection with Luminex beads for seven intestinal parasites. Am J Trop Med Hyg (2011) 2.10
Real-time-PCR assay for diagnosis of Entamoeba histolytica infection. J Clin Microbiol (2005) 2.06
Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infect Immun (2006) 1.99
Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entamoeba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh. Am J Trop Med Hyg (2003) 1.92
Attribution of malnutrition to cause-specific diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh. Am J Trop Med Hyg (2009) 1.71
Diagnosis of amebic liver abscess and amebic colitis by detection of Entamoeba histolytica DNA in blood, urine, and saliva by a real-time PCR assay. J Clin Microbiol (2010) 1.70
Innate and acquired resistance to amebiasis in bangladeshi children. J Infect Dis (2002) 1.68
The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. J Immunol (2002) 1.63
Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome. Mol Biochem Parasitol (2006) 1.55
A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J Clin Invest (2011) 1.55
Entamoeba histolytica phagocytosis of human erythrocytes involves PATMK, a member of the transmembrane kinase family. PLoS Pathog (2008) 1.46
Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study. Trans R Soc Trop Med Hyg (2006) 1.45
Apoptotic killing and phagocytosis of host cells by the parasite Entamoeba histolytica. Infect Immun (2003) 1.43
Comparison of a stool antigen detection kit and PCR for diagnosis of Entamoeba histolytica and Entamoeba dispar infections in asymptomatic cyst passers in Iran. J Clin Microbiol (2006) 1.42
Proteomic analysis of phagocytosis in the enteric protozoan parasite Entamoeba histolytica. Eukaryot Cell (2005) 1.37
Entamoeba histolytica encephalitis diagnosed by PCR of cerebrospinal fluid. Trans R Soc Trop Med Hyg (2006) 1.35
Molecular epidemiology of amebiasis. Infect Genet Evol (2008) 1.34
Tissue destruction and invasion by Entamoeba histolytica. Trends Parasitol (2011) 1.34
Setting research priorities to reduce mortality and morbidity of childhood diarrhoeal disease in the next 15 years. PLoS Med (2013) 1.34
Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. J Infect Dis (2004) 1.31
Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Vaccine (2004) 1.31
Incidence of respiratory virus-associated pneumonia in urban poor young children of Dhaka, Bangladesh, 2009-2011. PLoS One (2012) 1.28
Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study. Clin Infect Dis (2012) 1.27
Evidence for a link between parasite genotype and outcome of infection with Entamoeba histolytica. J Clin Microbiol (2006) 1.24
Tissue invasion by Entamoeba histolytica: evidence of genetic selection and/or DNA reorganization events in organ tropism. PLoS Negl Trop Dis (2008) 1.18
Correlation of interferon-gamma production by peripheral blood mononuclear cells with childhood malnutrition and susceptibility to amebiasis. Am J Trop Med Hyg (2007) 1.17
Identification and gene expression analysis of a large family of transmembrane kinases related to the Gal/GalNAc lectin in Entamoeba histolytica. Eukaryot Cell (2005) 1.17
Kinetics and strain variation of phagosome proteins of Entamoeba histolytica by proteomic analysis. Mol Biochem Parasitol (2005) 1.16
Evaluation of Entamoeba histolytica antigen and antibody point-of-care tests for the rapid diagnosis of amebiasis. J Clin Microbiol (2006) 1.16
Entamoeba histolytica and Entamoeba dispar utilize externalized phosphatidylserine for recognition and phagocytosis of erythrocytes. Infect Immun (2005) 1.12
Short hairpin RNA-mediated knockdown of protein expression in Entamoeba histolytica. BMC Microbiol (2009) 1.11
REG1B as a predictor of childhood stunting in Bangladesh and Peru. Am J Clin Nutr (2013) 1.09
Rapid Diagnosis of Intestinal Parasitic Protozoa, with a Focus on Entamoeba histolytica. Interdiscip Perspect Infect Dis (2009) 1.07
Entamoeba moshkovskii is associated with diarrhea in infants and causes diarrhea and colitis in mice. J Infect Dis (2012) 1.06
Role of interleukin 23 signaling in Clostridium difficile colitis. J Infect Dis (2013) 1.05
Histone acetyltransferases and deacetylase in Entamoeba histolytica. Mol Biochem Parasitol (2004) 1.04
Amebic colitis: new insights into pathogenesis and treatment. Curr Gastroenterol Rep (2007) 1.03
Cognitive effects of diarrhea, malnutrition, and Entamoeba histolytica infection on school age children in Dhaka, Bangladesh. Am J Trop Med Hyg (2006) 1.00
Longitudinal evaluation of enteric protozoa in Haitian children by stool exam and multiplex serologic assay. Am J Trop Med Hyg (2014) 1.00
Entamoeba bangladeshi nov. sp., Bangladesh. Emerg Infect Dis (2012) 0.99
Diagnosis of amebiasis in Bangladesh. Arch Med Res (2006) 0.99
Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles. J Infect Dis (2008) 0.99
VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit. Infect Immun (2003) 0.98
Evaluation of rapid antigen point-of-care tests for detection of Giardia and Cryptosporidium species in human fecal specimens. J Clin Microbiol (2011) 0.98
Seasonal concentrations and determinants of indoor particulate matter in a low-income community in Dhaka, Bangladesh. Environ Res (2012) 0.97
Members of the Entamoeba histolytica transmembrane kinase family play non-redundant roles in growth and phagocytosis. Int J Parasitol (2010) 0.97
Roles for the galactose-/N-acetylgalactosamine-binding lectin of Entamoeba in parasite virulence and differentiation. Glycobiology (2005) 0.96
Leptin protects host cells from Entamoeba histolytica cytotoxicity by a STAT3-dependent mechanism. Infect Immun (2012) 0.96
Host immune response to intestinal amebiasis. PLoS Pathog (2013) 0.96
Entamoeba histolytica: the serine-rich gene polymorphism-based genetic variability of clinical isolates from Georgia. Exp Parasitol (2005) 0.96
Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies. Curr Opin Immunol (2007) 0.96
Two cases of rarely recognized infection with Entamoeba moshkovskii. Am J Trop Med Hyg (2007) 0.95
Regulation of virulence of Entamoeba histolytica. Annu Rev Microbiol (2014) 0.94
Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon. Infect Immun (2009) 0.94
Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica. Infect Immun (2013) 0.93
Entamoeba histolytica: sequence conservation of the Gal/GalNAc lectin from clinical isolates. Exp Parasitol (2002) 0.93
Update on protozoan parasites of the intestine. Curr Opin Gastroenterol (2002) 0.93
Proteomic analysis of the cyst stage of Entamoeba histolytica. PLoS Negl Trop Dis (2012) 0.92
Calcium modulates promoter occupancy by the Entamoeba histolytica Ca2+-binding transcription factor URE3-BP. J Biol Chem (2002) 0.92
CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine. Vaccine (2010) 0.92
Targets of the Entamoeba histolytica transcription factor URE3-BP. PLoS Negl Trop Dis (2008) 0.91
Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infect Immun (2013) 0.90
Characterization of an Entamoeba histolytica high-mobility-group box protein induced during intestinal infection. Eukaryot Cell (2008) 0.90
Association between TNF-alpha and Entamoeba histolytica diarrhea. Am J Trop Med Hyg (2010) 0.89
The dynamic interdependence of amebiasis, innate immunity, and undernutrition. Semin Immunopathol (2012) 0.89
Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998. Am J Trop Med Hyg (2002) 0.88
Evaluation of a screening test for detection of giardia and cryptosporidium parasites. J Clin Microbiol (2008) 0.88
Giardia intestinalis assemblages A and B infections in Nepal. Am J Trop Med Hyg (2009) 0.88
The expression of REG 1A and REG 1B is increased during acute amebic colitis. Parasitol Int (2011) 0.88
Using differential gene expression to study Entamoeba histolytica pathogenesis. Trends Parasitol (2009) 0.88
Vaccine prospects for amebiasis. Expert Rev Vaccines (2005) 0.86
Expression and function of a family of transmembrane kinases from the protozoan parasite Entamoeba histolytica. Infect Immun (2006) 0.86
Phospholipid-binding protein EhC2A mediates calcium-dependent translocation of transcription factor URE3-BP to the plasma membrane of Entamoeba histolytica. Eukaryot Cell (2009) 0.85
Hepatic amebiasis: a reminder of the complications. Curr Opin Pediatr (2009) 0.85
Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children. J Infect Dis (2009) 0.84
Evaluation of a rapid point-of-care fecal antigen detection test for Entamoeba histolytica. Am J Trop Med Hyg (2012) 0.84
Mechanisms of adherence, cytotoxicity and phagocytosis modulate the pathogenesis of Entamoeba histolytica. Future Microbiol (2011) 0.83
Multisite performance evaluation of an enzyme-linked immunosorbent assay for detection of Giardia, Cryptosporidium, and Entamoeba histolytica antigens in human stool. J Clin Microbiol (2012) 0.83
A Multilocus Sequence Typing System (MLST) reveals a high level of diversity and a genetic component to Entamoeba histolytica virulence. BMC Microbiol (2012) 0.83
Indoor exposure to particulate matter and age at first acute lower respiratory infection in a low-income urban community in Bangladesh. Am J Epidemiol (2014) 0.83
Use of metagenomics to understand the genetic basis of malnutrition. Nutr Rev (2009) 0.83
Context-dependent roles of the Entamoeba histolytica core promoter element GAAC in transcriptional activation and protein complex assembly. Mol Biochem Parasitol (2002) 0.81
In vitro and in vivo interaction of Entamoeba histolytica Gal/GalNAc lectin with various target cells: an immunocytochemical analysis. Parasitol Int (2004) 0.81
Regulation of Virulence of Entamoeba histolytica by the URE3-BP Transcription Factor. MBio (2010) 0.81
Diagnosis of multiple enteric protozoan infections by enzyme-linked immunosorbent assay in the Guatemalan highlands. Am J Trop Med Hyg (2012) 0.81
The ways of a killer: how does Entamoeba histolytica elicit host cell death? Essays Biochem (2011) 0.81
Development of the Gateway system for cloning and expressing genes in Entamoeba histolytica. Parasitol Int (2008) 0.80
Promoter analysis of palindromic transcription units in the ribosomal DNA circle of Entamoeba histolytica. Eukaryot Cell (2008) 0.79
Common pathways for receptor-mediated ingestion of Escherichia coli and LDL cholesterol by Entamoeba histolytica regulated in part by transmembrane kinase 39. Int J Parasitol (2012) 0.79
The Entamoeba histolytica serum-inducible transmembrane kinase EhTMKB1-9 is involved in intestinal amebiasis. Int J Parasitol Drugs Drug Resist (2012) 0.78
Comparison of two immunoassays for detection of Entamoeba histolytica. J Clin Microbiol (2008) 0.78